2010
DOI: 10.1373/clinchem.2010.145359
|View full text |Cite
|
Sign up to set email alerts
|

Galactosemia Diagnosis Gets an Upgrade

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0
3

Year Published

2011
2011
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 7 publications
0
7
0
3
Order By: Relevance
“…Increased galactose-1-phosphate accumulates in the liver, kidney, brain, tongue, lens, and cutaneous fibroblasts, and causes injury. In many patients, jaundice, hepatosplenomegaly, hepatic failure, feeding difficulties, hypoglycemia, renal tubular dysfunction, muscular hypotonia, sepsis, and cataracts are observed following intake of galactose in the neonatal period (3,4). Rapid symptom regression occurs with early initiation of treatment, but outcomes that affect life negatively in the short and long term may be observed (1).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Increased galactose-1-phosphate accumulates in the liver, kidney, brain, tongue, lens, and cutaneous fibroblasts, and causes injury. In many patients, jaundice, hepatosplenomegaly, hepatic failure, feeding difficulties, hypoglycemia, renal tubular dysfunction, muscular hypotonia, sepsis, and cataracts are observed following intake of galactose in the neonatal period (3,4). Rapid symptom regression occurs with early initiation of treatment, but outcomes that affect life negatively in the short and long term may be observed (1).…”
Section: Introductionmentioning
confidence: 99%
“…Close monitoring is necessary in patients with classic galactosemia because of all these factors mentioned above (3)(4)(5). These patients will remain on a special diet throughout their lives and it is recommended that they are followed up by a multidisciplinary team.…”
Section: Introductionmentioning
confidence: 99%
“…In humans, a deficiency of the second enzyme of the Leloir pathway, galactose-1-phosphate uridylyltransferase (GALT, E.C. 2.7.7.12), results in the autosomal recessive, potentially lethal disorder classic galactosemia ( OMIM 230400) (Fridovich-Keil and Walter, 2008; Bennett, 2010; Bosch, 2011). …”
Section: Introductionmentioning
confidence: 99%
“…Galaktoz ve metabolitlerinin ayrıca tiroid fonksiyonlarını da etkileyebileceği bildirilmiştir. 20 Bunun nedeninin karaciğer kaynaklı olan tiroid bağlayıcı globulinin yetersiz sentezi olduğu düşü-nülmektedir. Geçici hipotiroksinemi preterm bebeklerde sık görülmesine rağmen term bebeklerde nadirdir.…”
Section: Discussionunclassified